An Alzheimer’s Disease-Derived Biomarker Signature Identifies Parkinson’s Disease Patients with Dementia

2014 Update of the Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception

(2015) Michael W. Weiner et al.   Alzheimers & Dementia

Unbiased Approaches to Biomarker Discovery in Neurodegenerative Diseases

(2014) Alice S. Chen-Plotkin   NEURON

Two Phase 3 Trials of Bapineuzumab in Mild-to-Moderate Alzheimer's Disease

(2014) Stephen Salloway et al.   NEW ENGLAND JOURNAL OF MEDICINE

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

(2014) Rachelle S. Doody et al.   NEW ENGLAND JOURNAL OF MEDICINE

Neuropathologic substrates of Parkinson disease dementia

(2012) David J. Irwin et al.   ANNALS OF NEUROLOGY

Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson’s disease patients

(2012) Maria Teresa Pellecchia et al.   JOURNAL OF NEUROLOGY

GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology

(2012) D. Tsuang et al.   NEUROLOGY

Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease

(2011) D. Weintraub et al.   BRAIN

Lewy- and Alzheimer-type pathologies in Parkinson's disease dementia: which is more important?

(2011) Y. Compta et al.   BRAIN

The Parkinson Progression Marker Initiative (PPMI)

(2011) Kenneth Marek et al.   PROGRESS IN NEUROBIOLOGY

Biomarkers for Parkinson's Disease

(2011) T. B. Sherer   Science Translational Medicine

Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression

(2010) Kenneth Marek et al.   ANNALS OF NEUROLOGY

Plasma epidermal growth factor levels predict cognitive decline in Parkinson disease

(2010) Alice S. Chen-Plotkin et al.   ANNALS OF NEUROLOGY

Synergistic Interactions between A , Tau, and  -Synuclein: Acceleration of Neuropathology and Cognitive Decline

(2010) L. K. Clinton et al.   JOURNAL OF NEUROSCIENCE

Geographic and Ethnic Variation in Parkinson Disease: A Population-Based Study of US Medicare Beneficiaries

(2010) Allison Wright Willis et al.   NEUROEPIDEMIOLOGY

CSF amyloid   1-42 predicts cognitive decline in Parkinson disease

(2010) A. Siderowf et al.   NEUROLOGY

What are biomarkers?

(2010) Kyle Strimbu et al.   Current Opinion in HIV and AIDS

Parkinson Disease With Dementia

(2009) Marwan N. Sabbagh et al.   ALZHEIMER DISEASE & ASSOCIATED DISORDERS

Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects

(2009) Leslie M. Shaw et al.   ANNALS OF NEUROLOGY

Longitudinal progression of Alzheimer's-like patterns of atrophy in normal older adults: the SPARE-AD index

(2009) C. Davatzikos et al.   BRAIN

The distinct cognitive syndromes of Parkinson's disease: 5 year follow-up of the CamPaIGN cohort

(2009) Caroline H. Williams-Gray et al.   BRAIN

Glucocerebrosidase mutations in clinical and pathologically proven Parkinson's disease

(2009) Juliane Neumann et al.   BRAIN

Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort

(2009) E. Y. Uc et al.   NEUROLOGY

Prevalence and impact of vascular and Alzheimer pathologies in Lewy body disease

(2008) Kurt A. Jellinger et al.   ACTA NEUROPATHOLOGICA

A critical reappraisal of current staging of Lewy-related pathology in human brain

(2008) Kurt A. Jellinger   ACTA NEUROPATHOLOGICA

Striatal β-Amyloid Deposition in Parkinson Disease With Dementia

(2008) Michail E. Kalaitzakis et al.   JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY

Dementia and survival in Parkinson disease: A 12-year population study

(2008) T. C. Buter et al.   NEUROLOGY